⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7891 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL341034 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL308873 | 0.95 | — | — | |
| Methylene Chloride SCHEMBL28991838 | 0.95 | — | — | |
| SCHEMBL9001123 | 0.95 | — | — | |
| SCHEMBL10604312 | 0.95 | — | — | |
| SCHEMBL4485842 | 0.95 | — | — | |
| Water SCHEMBL11864826 | 0.95 | — | — | |
| Charcoal, Activated SCHEMBL31348358 | 0.95 | — | — | |
| Fluoride SCHEMBL27659501 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1503798-B8 | STABILISED SOLID COMPOSITIONS OF MODIFIED FACTOR VII | NOVO NORDISK HEALTHCARE AG (CH) | 2012-03-14 | — | — | EP | claimed |
| US-20090075895-A1 | Stabilised Solid Composition of Modified Factor VII | NOVO NORDISK A/S (DK) | 2009-03-19 | — | — | US | claimed |
| US-20070049523-A1 | Liquid composition of modified factor VII polypeptides | NOVO NORDISK A/S (DK) | 2007-03-01 | — | — | US | claimed |
| EP-1503798-A1 | STABILISED SOLID COMPOSITIONS OF MODIFIED FACTOR VII | NOVO NORDISK A/S (DK) | 2005-02-09 | — | — | EP | claimed |
| EP-1458407-A1 | LIQUID COMPOSITION OF MODIFIED FACTOR VII POLYPEPTIDES | NOVO NORDISK A/S (DK) | 2004-09-22 | — | — | EP | claimed |
| US-20040043933-A1 | Liquid composition of modified factor VII polypeptides | NOVO NORDISK HEALTHCARE A/G (CH) | 2004-03-04 | — | — | US | claimed |
| US-20040009918-A1 | Stabilised solid compositions of modified factor VII | NOVO NORDISK HEALTHCARE AG (CH) | 2004-01-15 | — | — | US | claimed |
| WO-2003092731-A1 | STABILISED SOLID COMPOSITIONS OF MODIFIED FACTOR VII | NOVO NORDISK A/S (DK) | 2003-11-13 | — | — | WO | claimed |
| WO-2003055511-A1 | LIQUID COMPOSITION OF MODIFIED FACTOR VII POLYPEPTIDES | NOVO NORDISK A/S (DK) | 2003-07-10 | — | — | WO | claimed |
| EP-2307425-A1 | IMIDAZOTHIADIAZOLES DERIVATIVES | Merck Patent GmbH (DE) | 2011-04-13 | — | — | EP | disclosed |
| WO-2010012345-A1 | IMIDAZOTHIADIAZOLES DERIVATIVES | MERCK PATENT GMBH (DE) | 2010-02-04 | — | — | WO | disclosed |
| US-20070049523-A1 | Liquid composition of modified factor VII polypeptides | NOVO NORDISK A/S (DK) | 2007-03-01 | — | — | US | disclosed |
| EP-1458407-A1 | LIQUID COMPOSITION OF MODIFIED FACTOR VII POLYPEPTIDES | NOVO NORDISK A/S (DK) | 2004-09-22 | — | — | EP | disclosed |
| US-20040043933-A1 | Liquid composition of modified factor VII polypeptides | NOVO NORDISK HEALTHCARE A/G (CH) | 2004-03-04 | — | — | US | disclosed |
| WO-2003055511-A1 | LIQUID COMPOSITION OF MODIFIED FACTOR VII POLYPEPTIDES | NOVO NORDISK A/S (DK) | 2003-07-10 | — | — | WO | disclosed |